- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01492595
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (TBcontact)
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital
Přehled studie
Postavení
Podmínky
Detailní popis
Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children <5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.
The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.
Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.
Typ studie
Zápis (Aktuální)
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.
- Informed consent signed by the parent or legal guardian
- Living within a 2-hour radius of Mbarara town
Exclusion Criteria:
- Child currently receiving anti-tuberculosis treatment
- Child has received a full course of anti-TB treatment within the last 6 months
Studijní plán
Jak je studie koncipována?
Detaily designu
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection
Časové okno: Baseline
|
Baseline
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Number of children <5 years exposed to TB in the household of adult index cases
Časové okno: Baseline
|
Baseline
|
|
Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography
Časové okno: 9 months
|
9 months
|
|
Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB
Časové okno: 9 months
|
9 months
|
|
Median duration of exposure to symptomatic source case among the contacts in the various classes
Časové okno: Baseline
|
Baseline
|
|
Association of various risk factors with the final classification of contacts after assessment
Časové okno: 9 months
|
9 months
|
|
Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children
Časové okno: 9 months
|
9 months
|
|
Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)
Časové okno: 9 months
|
9 months
|
|
Proportion of adverse events on treatment of TB disease, LTBI and TB exposure
Časové okno: 9 months
|
9 months
|
|
Adherence to IPT regimens
Časové okno: 9 months
|
9 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Julius Kiwanuka, MD, Mbarara University of Science and Technology
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- Epicentre/MBA/2011/TBcontact
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Tuberkulóza
-
University Children's Hospital BaselUniversity Hospital, Geneva; University Hospital Inselspital, Berne; Kantonsspital... a další spolupracovníciNábor
-
National Institute of Allergy and Infectious Diseases...DokončenoMycobacterium tuberculosisBrazílie
-
The University of Texas Health Science Center,...National Institute of Allergy and Infectious Diseases (NIAID)DokončenoMycobacterium tuberculosisSpojené státy, Kolumbie, Mexiko
-
National Institute of Allergy and Infectious Diseases...Aktivní, ne náborOportunní infekce | Mycobacterium tuberculosis | Netuberkulózní mykobakteriaThajsko, Čína, Tchaj-wan
-
Johns Hopkins UniversityUkončeno
-
National Institute of Allergy and Infectious Diseases...Dokončeno
-
Nagasaki UniversityZatím nenabírámeTuberkulóza | Mycobacterium tuberculosis | Plicní tuberkulózyKeňa
-
Assistance Publique - Hôpitaux de ParisViatris Inc.Zatím nenabírámeOdolnost vůči antibiotikům | Mycobacterium tuberculosis | MDR-TB | Aktivní multirezistentní tuberkulózaFrancie
-
National Institute of Allergy and Infectious Diseases...Dokončeno
-
François SpertiniUniversity of OxfordDokončenoTuberkulóza | Mycobacterium Tuberculosis, ochrana protiŠvýcarsko